Pharmalys integrates corporate social responsibility (CSR) into its operational and strategic framework, with a focus on strengthening clinical research systems and contributing to sustainable healthcare development globally, and in Africa in particular.
A strutured and long-term commitment
The company’s CSR approach is built on three pillars: Quality of Life, Equality and Fairness, and Standards of Work. These pillars provide a consistent framework for initiatives that address both internal practices and external impact, ensuring alignment with long term development objectives.
This approach is closely aligned with several United Nations Sustainable Development Goals (SDGs), notably those related to health, education, gender equality, economic development, innovation, and partnerships.
Advancing access to healthcare and public health outcomes
Pharmalys contributes to improving access to healthcare through support for medical programmes targeting underserved populations, including diagnostic and consultation initiatives in areas with limited infrastructure.
In parallel, its involvement in clinical research has supported the development of vaccines addressing major public health challenges, including malaria. These contributions illustrate the role of high quality clinical research in improving health outcomes at scale.
Employee wellbeing also remains a priority, with policies supporting healthcare access, work-life balance, and safe working conditions across a geographically distributed workforce.
Developing skills and strengthening capacity
A central component of Pharmalys’ CSR strategy is investment in education and professional development within the clinical research sector. Through initiatives such as the Pharmalys Academy of Clinical research Excellence (PACE), the company contributes to bridging the gap between academic training and industry requirements.
Additional programmes, including mentorship, apprenticeships, and internal mobility initiatives, support continuous skills development and workforce adaptability. These efforts contribute to building a critical mass of qualified professionals capable of supporting the growth of clinical research, particularly in emerging markets.
Promoting inclusion and fair practices
Pharmalys maintains a structured approach to inclusion and fairness, supported by internal policies that promote equal opportunities, equitable remuneration, and a respectful working environment.
The company demonstrates strong representation of women across its workforce, including in leadership and operational roles, alongside a continued focus on maintaining pay equity and supporting career progression based on competencies and performance.
Supporting economic development and sustainable practices
Through its activities, Pharmalys contributes to job creation, skills transfer, and local economic development, both directly and through its wider network of partners and service providers.
Environmental considerations are integrated into operational practices, including the promotion of remote working, responsible travel policies, and paperless systems, contributing to the reduction of the company’s overall environmental footprint.
Collaboration and future outlook
Collaboration with NGOs, academic institutions, and global partners remains a key component of Pharmalys’ approach, enabling the delivery of clinical research programmes and capacity building initiatives at scale. Through these partnerships, Pharmalys provides reliable clinical trial data that supports the medical community in advancing knowledge of diseases and the development of effective treatments.
Pharmalys will continue to develop its CSR strategy in line with evolving global health priorities, with a sustained focus on quality, impact, and the expansion of clinical research capabilities across underrepresented regions.
Download the full Corporate Social Responsibility brochure here.
